Status:
COMPLETED
Comparative Cycle Control Europe
Lead Sponsor:
Bayer
Conditions:
Contraception
Eligibility:
FEMALE
18-50 years
Phase:
PHASE3
Brief Summary
The aim of this study is to evaluate bleeding pattern, cycle control, and safety of this new four-phasic oral contraceptive in comparison to a reference OC.
Detailed Description
The study has previously been posted by Schering AG, Germany. Schering AG, Germany has been renamed to Bayer Schering Pharma AG, Germany.Bayer Schering Pharma AG, Germany is the sponsor of the trial.
Eligibility Criteria
Inclusion
- Healthy female volunteers aged between 18 and 50 years requiring contraception
Exclusion
- Pregnancy or lactation
- Any conditions that might interfere with the outcome as well as all contraindications for OC use
Key Trial Info
Start Date :
March 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2006
Estimated Enrollment :
798 Patients enrolled
Trial Details
Trial ID
NCT00185367
Start Date
March 1 2005
End Date
September 1 2006
Last Update
July 15 2011
Active Locations (34)
Enter a location and click search to find clinical trials sorted by distance.
1
Soukroma gynekologicka ambulance
Fulnek, Czechia, 74245
2
Soukroma gynekologicka ambulance
Pilsen, Czechia, 30708
3
Provozorna Gynekologicka ordinace Dr. Tesar
Prague, Czechia, 109 00
4
Femina Sana s.r.o
Prague, Czechia, 13000